Transplant Diagnostics Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Transplant Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.8% during the forecast period.

    This report presents the market size and development trends by detailing the Transplant Diagnostics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Transplant Diagnostics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Transplant Diagnostics industry and will help you to build a panoramic view of the industrial development.

    Transplant Diagnostics Market, By Type:

    • Solid Organ Transplantation

    • Stem Cell Transplantation

    • Soft Tissue Transplantation

    Transplant Diagnostics Market, By Application:

    • Independent Reference Laboratories

    • Hospitals & Transplant Centers

    • Research Laboratories & Academic Institutes

    Some of the leading players are as follows:

    • F. Hoffman-La Roche

    • Thermo Fisher Scientific

    • Gendx

    • Immucor

    • F Hoffman-La Roche

    • Biofortuna

    • BD

    • Bio-Rad Laboratories

    • Biomérieux SA

    • Merck KGaA

    • Qiagen

    • Caredx

    • Illumina

    • Luminex

    • Omixon

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Transplant Diagnostics Market: Technology Type Analysis

    • 4.1 Transplant Diagnostics Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Transplant Diagnostics Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Solid Organ Transplantation

      • 4.3.2 Stem Cell Transplantation

      • 4.3.3 Soft Tissue Transplantation

    5 Transplant Diagnostics Market: Product Analysis

    • 5.1 Transplant Diagnostics Product Market Share Analysis, 2018 & 2026

    • 5.2 Transplant Diagnostics Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Transplant Diagnostics Market: Application Analysis

    • 6.1 Transplant Diagnostics Application Market Share Analysis, 2018 & 2026

    • 6.2 Transplant Diagnostics Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Independent Reference Laboratories

      • 6.3.2 Hospitals & Transplant Centers

      • 6.3.3 Research Laboratories & Academic Institutes

    7 Transplant Diagnostics Market: Regional Analysis

    • 7.1 Transplant Diagnostics Regional Market Share Analysis, 2018 & 2026

    • 7.2 Transplant Diagnostics Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 F. Hoffman-La Roche

      • 9.1.1 F. Hoffman-La Roche Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Thermo Fisher Scientific

      • 9.2.1 Thermo Fisher Scientific Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Gendx

      • 9.3.1 Gendx Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Immucor

      • 9.4.1 Immucor Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 F Hoffman-La Roche

      • 9.5.1 F Hoffman-La Roche Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Biofortuna

      • 9.6.1 Biofortuna Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 BD

      • 9.7.1 BD Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Bio-Rad Laboratories

      • 9.8.1 Bio-Rad Laboratories Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Biomérieux SA

      • 9.9.1 Biomérieux SA Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Merck KGaA

      • 9.10.1 Merck KGaA Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Qiagen

      • 9.11.1 Qiagen Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Caredx

      • 9.12.1 Caredx Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Illumina

      • 9.13.1 Illumina Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Luminex

      • 9.14.1 Luminex Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Omixon

      • 9.15.1 Omixon Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

     

    The List of Tables and Figures (Totals 82 Figures and 160 Tables)

    • Figure Solid Organ Transplantation Transplant Diagnostics market, 2015 - 2026 (USD Million)

    • Figure Stem Cell Transplantation Transplant Diagnostics market, 2015 - 2026 (USD Million)

    • Figure Soft Tissue Transplantation Transplant Diagnostics market, 2015 - 2026 (USD Million)

    • Figure Independent Reference Laboratories market, 2015 - 2026 (USD Million)

    • Figure Hospitals & Transplant Centers market, 2015 - 2026 (USD Million)

    • Figure Research Laboratories & Academic Institutes market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Transplant Diagnostics market, by country, 2015 - 2026 (USD Million)

    • Table North America Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table North America Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table North America Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Canada Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Canada Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Europe Transplant Diagnostics market, by country, 2015 - 2026 (USD Million)

    • Table Europe Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Europe Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Europe Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Germany Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Germany Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table France Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table France Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Italy Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Italy Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Spain Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Spain Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Transplant Diagnostics market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table China Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table China Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Japan Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Japan Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table India Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table India Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Transplant Diagnostics market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table MEA Transplant Diagnostics market, by country, 2015 - 2026 (USD Million)

    • Table MEA Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table MEA Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table MEA Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Transplant Diagnostics market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Transplant Diagnostics market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Transplant Diagnostics market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table F. Hoffman-La Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Gendx Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Immucor Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table F Hoffman-La Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biofortuna Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BD Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biomérieux SA Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck KGaA Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Qiagen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Caredx Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Illumina Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Luminex Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Omixon Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.